Supply Chain

Ten hospitals and health systems posted job listings for supply chain expertise in the last week:

The U.S. has made significant strides to expand COVID-19 testing since the pandemic began, and testing remains critical to tracking the spread of the virus. But the U.S. may face another shortage of tests if there is a second wave…

Johnson & Johnson and Zimmer Biomet are among the medical device companies that Moody's Investors Service expects to be most negatively affected by the COVID-19 pandemic, MedTech Dive reported. 

3M filed a lawsuit in a California federal court alleging an Amazon seller defrauded customers by charging "grossly inflated" prices for fake, defective and damaged respirator products. 

Amid a lack of federal regulation of lab charges, a diagnostic lab in Texas has charged insurers as much as $2,315 for the same COVID-19 test that costs $100 elsewhere, The New York Times reported. 

As drugmakers race to develop a COVID-19 vaccine, a shortage of medical glass needed to make vials to contain the vaccine may delay when the public gets it, The Wall Street Journal reported. 

As surgeries begin to resume across the country, so too will your facility’s freight management needs.  The following checklist from our OptiFreight® Logistics team will help ensure your facility is ready to resume shipping on a larger scale.

While many states have eased coronavirus lockdown measures, testing remains critical to tracking and preventing the spread of COVID-19. 

Eight drugs and medical devices approved by the FDA since May 4:

Fillakit, a company formed May 1, was granted a $10.2 million contract from the federal government to make COVID-19 testing supplies despite having no experience in making medical supplies, the Tampa Bay Times reported.